About: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1988

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1988 (uk) im Januar 1988 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1988 (ast) artikull shkencor i botuar më 01 janar 1988 (sq) scientific article published on 01 January 1988 (en)
publication date	wds:Q70378598-6510F8D7-D504-4112-9E4A-08CD64F16F8D
publication date	1988-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70378598-9D269456-36FA-45F2-8579-424630184FCD
language of work or name	English
cites work	wds:Q70378598-07ADB37A-A95D-4F87-99C9-2128A9EE6BE9 wds:Q70378598-0F1AE4A5-16FF-4880-B0A8-922742B6E3E3 wds:Q70378598-1B1A67CE-8D34-4A1F-AA8F-3C4BB3C9C585 wds:Q70378598-1E60F696-E482-4581-9E1B-9098AD952D9E wds:Q70378598-2D073B6E-A3B4-4B97-807C-DBC7CA5C16AE wds:Q70378598-3498BEFF-B2BB-4379-B68B-21285FDC7DBE wds:Q70378598-40B5BBD8-B493-44E1-8AAD-63833861F0B2 wds:Q70378598-4165788B-695C-46D5-B84C-19C97A3F97C6 wds:Q70378598-44F88CC0-A061-4087-832E-73634AD0935E wds:Q70378598-66EBA25D-9B4A-46D1-9C07-82C46722C037 wds:Q70378598-682163B1-C5CA-4531-968A-B685258165FB wds:Q70378598-77F962D6-F009-4D1A-B6EE-43F3A1B15384 wds:Q70378598-7FFC4C74-71C9-446F-9FBB-1E19B4FFD75B wds:Q70378598-80C5A30F-52D2-4353-8991-1B6697688947 wds:Q70378598-82A6BEEA-5AAD-472B-A629-A555C5833DD8 wds:Q70378598-852C2992-3EAD-4752-A1ED-EBAFCE0AB788 wds:Q70378598-957697EF-A3AE-4DB2-B216-E279094B99FB wds:Q70378598-9784EAAA-9F4E-45A6-8DC3-577EA5FF9109 wds:Q70378598-A5943AD8-EF1E-4B61-93AB-0F9A03B67BF5 wds:Q70378598-A79ABE0A-0710-4D88-B3CC-11CB9DDB0A1D wds:Q70378598-A8C2CD8B-D7C5-428F-A074-7CAC6C42E79E wds:Q70378598-AD4AB019-C9B6-476A-96F9-2890A65D90DC wds:Q70378598-B34CEF58-7F3C-4CBC-9C07-AA81BDB0820B wds:Q70378598-C50D5A5F-02F2-4A94-8B27-29522C6B9294 wds:Q70378598-C657C120-3418-44C0-9FCA-362E1674C86E wds:Q70378598-C7556FFC-01D5-49EF-8071-B0481D07909D wds:Q70378598-C9F492C5-3E85-41D8-B0DA-546D3420E41E wds:Q70378598-CFD8625D-529C-4CF5-9274-0EE00AE03BFC wds:Q70378598-D538FFAD-CD69-4B9F-90C6-931F0235A3D8 wds:Q70378598-DE54EDB5-5391-4887-A6C0-7F253DEB1E2F wds:Q70378598-E8511D7C-871D-4A3E-BF03-D34BF3C7A909 wds:Q70378598-FDFADA88-2266-4957-B3C3-E3D26E0A3706
cites work	[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial] Clinical pharmacology of platelet cyclooxygenase inhibition Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial Controlled trial of aspirin in cerebral ischemia Aspirin and secondary mortality after myocardial infarction Beta blockade during and after myocardial infarction: an overview of the randomized trials Dipyridamole Controlled Trial of Dipyridamole in Cerebral Vascular Disease Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Cumulative antiplatelet effect of low-dose enteric coated aspirin Controlled trial of aspirin in cerebral ischemia. Part II: surgical group The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials A randomized trial of aspirin and sulfinpyrazone in patients with TIA A randomized trial of aspirin and beta-carotene among U.S. physicians A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study Proceedings: The effect of a platelet inhibiting drug (sulfinpyrazone) in the therapy of patients with transient ischemic attacks (Tia's) and minor strokes Prolongation of bleeding time and inhibition of platelet aggregation by low-dose acetylsalicylic acid in patients with cerebrovascular disease Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily). Effects on platelet aggregation and thromboxane formation Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease. Current medical and surgical therapy for cerebrovascular disease ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)] The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics Aspirin for the prevention of coronary thrombosis: current facts and perspectives Aspirin in the prevention of myocardial infarction. Current status Aspirin in coronary heart disease. Comparison of six clinical trials Canadian American ticlopidine study (cats) in thromboembolic stroke.
rdfs:label	Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (en) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (nl) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (sq)
skos:prefLabel	Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (en) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (nl) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (sq)
name	Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (en) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (nl) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (sq)
title	wds:Q70378598-9415F2AB-5385-4DBA-9728-AAF1F4A277BA
title	Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration (en)
page(s)	wds:Q70378598-E0254A4B-7D2D-4508-B15C-67AC583E7779
page(s)	320-331
instance of	wds:Q70378598-33F53346-0E60-4D70-91DA-F069D651CEF6
instance of	scholarly article
main subject	wds:Q70378598-2ACF8CCB-F9C4-4CAD-9190-81A38A15010D wds:Q70378598-4B004E37-621E-48C2-9EC3-13626345840D
main subject	prevention vascular disease
PubMed ID	wds:Q70378598-20113211-FD81-47B7-A9CE-A8689A7C8D55
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3125883
PubMed ID	3125883
published in	wds:Q70378598-3413D8DA-0DFF-4356-B38E-275BE6BB7D71
published in	BMJ - General Practice Edition
issue	wds:Q70378598-62F97B7F-0AA1-4FEC-938E-EF1BA2124728

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software